Global Oral Rehydration Salts III (ORS III) Market Growth (Status and Outlook) 2025-2031
Description
The global Oral Rehydration Salts III (ORS III) market size is predicted to grow from US$ 600 million in 2025 to US$ 861 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.
Oral Rehydration Salts III (ORS III) is a compound preparation mainly composed of sodium chloride, potassium chloride, sodium citrate and glucose. It is used to prevent and correct mild to moderate dehydration caused by diarrhea and other conditions by replenishing electrolytes and water. It can also regulate the body's water, electrolyte and acid - base balance. It tastes good and is easy to take, being a commonly used drug for treating dehydration and electrolyte disorders.
United States market for Oral Rehydration Salts III (ORS III) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oral Rehydration Salts III (ORS III) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oral Rehydration Salts III (ORS III) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oral Rehydration Salts III (ORS III) players cover Abbott, Otsuka, Bharat Biotech, AmJan, FDC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Oral Rehydration Salts III (ORS III) Industry Forecast” looks at past sales and reviews total world Oral Rehydration Salts III (ORS III) sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Rehydration Salts III (ORS III) sales for 2025 through 2031. With Oral Rehydration Salts III (ORS III) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Rehydration Salts III (ORS III) industry.
This Insight Report provides a comprehensive analysis of the global Oral Rehydration Salts III (ORS III) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Rehydration Salts III (ORS III) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Rehydration Salts III (ORS III) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Rehydration Salts III (ORS III) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Rehydration Salts III (ORS III).
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Rehydration Salts III (ORS III) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Powder
Tablet
Solution
Segmentation by Application:
Children
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Otsuka
Bharat Biotech
AmJan
FDC
Halewood Laboratories
Nutriset
DripDrop
Pendopharm
Primmed
SiNi Pharma
Anhui Jiuhua&Huayaun Pharmaceutical
Sichuan Kelun Pharmaceutical
Please note: The report will take approximately 2 business days to prepare and deliver.
Oral Rehydration Salts III (ORS III) is a compound preparation mainly composed of sodium chloride, potassium chloride, sodium citrate and glucose. It is used to prevent and correct mild to moderate dehydration caused by diarrhea and other conditions by replenishing electrolytes and water. It can also regulate the body's water, electrolyte and acid - base balance. It tastes good and is easy to take, being a commonly used drug for treating dehydration and electrolyte disorders.
United States market for Oral Rehydration Salts III (ORS III) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oral Rehydration Salts III (ORS III) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oral Rehydration Salts III (ORS III) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oral Rehydration Salts III (ORS III) players cover Abbott, Otsuka, Bharat Biotech, AmJan, FDC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Oral Rehydration Salts III (ORS III) Industry Forecast” looks at past sales and reviews total world Oral Rehydration Salts III (ORS III) sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Rehydration Salts III (ORS III) sales for 2025 through 2031. With Oral Rehydration Salts III (ORS III) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Rehydration Salts III (ORS III) industry.
This Insight Report provides a comprehensive analysis of the global Oral Rehydration Salts III (ORS III) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Rehydration Salts III (ORS III) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Rehydration Salts III (ORS III) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Rehydration Salts III (ORS III) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Rehydration Salts III (ORS III).
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Rehydration Salts III (ORS III) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Powder
Tablet
Solution
Segmentation by Application:
Children
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Otsuka
Bharat Biotech
AmJan
FDC
Halewood Laboratories
Nutriset
DripDrop
Pendopharm
Primmed
SiNi Pharma
Anhui Jiuhua&Huayaun Pharmaceutical
Sichuan Kelun Pharmaceutical
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
110 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Oral Rehydration Salts III (ORS III) Market Size by Player
- 4 Oral Rehydration Salts III (ORS III) by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Oral Rehydration Salts III (ORS III) Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
